Xenon Pharmaceuticals Market Sentiment

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,634.46+0.16%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

Xenon Pharmaceuticals Inc

XENENASDAQ

Trade with Public

$38.02

-0.91-2.34%

Last update: Oct 2, 4:42 PM

$37.28

-1.65-4.24%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Xenon Pharmaceuticals Market Sentiment - Benzinga

Xenon Pharmaceuticals Market Sentiment

Market sentiment signals for Xenon Pharmaceuticals (XENE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.7% short float

Options Flow▲ 0.13 P/C ratio

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

0.13

More calls — Bullish

278 calls · 36 puts

Avg Consensus PT

$61

+64.4%

Highest Price Target

$90

+141.4%

Baird

Lowest Price Target

$46

+23.4%

Deutsche Bank

Short Interest

6.7%

Rising — Bearish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	RBC Capital	Brian Abrahams—	+87.8%	$81 → $70	Maintained	Outperform
Sep 18, 2026	Wedbush	Laura Chico—	+47.5%	$71 → $55	Maintained	Outperform
Sep 18, 2026	Wells Fargo	Benjamin Burnett—	+71.7%	$69 → $64	Maintained	Overweight
Sep 18, 2026	Deutsche Bank	David Hoang—	+23.4%	$90 → $46	Downgrade	Buy→Hold
Sep 18, 2026	Needham	Serge Belanger—	+60.9%	$78 → $60	Maintained	Buy
Sep 18, 2026	Baird	Brian Skorney—	+141.4%	$97 → $90	Maintained	Outperform
Aug 7, 2026	RBC Capital	Brian Abrahams—	+117.3%	$82 → $81	Maintained	Outperform
May 27, 2026	JP Morgan	Tessa Romero—	+120.0%	$80 → $82	Maintained	Overweight
May 12, 2026	JP Morgan	Tessa Romero—	+114.6%	$77 → $80	Maintained	Overweight
May 8, 2026	RBC Capital	Brian Abrahams—	+120.0%	$80 → $82	Maintained	Outperform
May 8, 2026	Needham	Serge Belanger—	+109.2%	$80 → $78	Maintained	Buy
Mar 16, 2026	Wedbush	Laura Chico—	+69.0%	$64 → $63	Maintained	Outperform
Mar 10, 2026	Wells Fargo	Benjamin Burnett—	+82.4%	$49 → $68	Maintained	Overweight
Mar 10, 2026	Wedbush	Laura Chico—	+71.7%	$47 → $64	Maintained	Outperform
Mar 10, 2026	Deutsche Bank	David Hoang—	+141.4%	$56 → $90	Maintained	Buy
Mar 10, 2026	HC Wainwright & Co.	Douglas Tsao—	+98.5%	$53 → $74	Maintained	Buy
Mar 9, 2026	Needham	Serge Belanger—	+114.6%	$58 → $80	Maintained	Buy
Mar 9, 2026	Baird	Brian Skorney—	+160.2%	$63 → $97	Maintained	Outperform
Feb 27, 2026	Needham	Serge Belanger—	+55.6%	$55 → $58	Maintained	Buy
Feb 27, 2026	Wells Fargo	Benjamin Burnett—	+31.4%	$48 → $49	Maintained	Overweight
Feb 24, 2026	Wolfe Research	Rudy Li—	+60.9%	$60	Initiate	Outperform
Jan 9, 2026	JP Morgan	Tessa Romero—	+66.3%	$60 → $62	Maintained	Overweight
Dec 11, 2025	Wells Fargo	Benjamin Burnett—	+28.8%	$44 → $48	Maintained	Overweight
Nov 18, 2025	JP Morgan	Tessa Romero—	+60.9%	$57 → $60	Maintained	Overweight
Nov 4, 2025	RBC Capital	Brian Abrahams—	+55.6%	$55 → $58	Maintained	Outperform